ECDC – EMCDDA cooperation aims to build a healthier Europe
ECDC's Director Andrea Ammon welcomed Alexis Goosdeel, the Director of the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) for an official visit this week, during which the two agencies discussed opportunities for further collaboration.
Since signing a formal EMCDDA–ECDC cooperation agreement in 2007, the two agencies have worked together on collecting, analysing and disseminating data, particularly in the area of monitoring drug-related infectious diseases (e.g. HIV, HCV and HBV). In 2011, the agencies issued joint guidance on the Prevention and control of infectious diseases among people who inject drugs.
During this week’s meeting, agency representatives met to discuss, among other topics: proposals to promote greater involvement of drug services in infectious disease testing (to complement European Testing Week); ways of improving the surveillance and monitoring capacity of EU Member States (with a particular focus on HCV); and the provision of evidence-based information and best practice for EU Member States and EU institutions.
Working in partnership with EMCDDA is an important component of the ECDC’s work programme for 2018. Among the initiatives planned are a series of joint country missions and the release of guidance on the prevention of communicable diseases in prison settings. Further exchange of knowledge and sharing of best practice between agencies is also an important part of this collaboration.